| pubmed-article:19819617 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19819617 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19819617 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19819617 | lifeskim:mentions | umls-concept:C0005684 | lld:lifeskim |
| pubmed-article:19819617 | lifeskim:mentions | umls-concept:C0004587 | lld:lifeskim |
| pubmed-article:19819617 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:19819617 | lifeskim:mentions | umls-concept:C1282910 | lld:lifeskim |
| pubmed-article:19819617 | lifeskim:mentions | umls-concept:C0014582 | lld:lifeskim |
| pubmed-article:19819617 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
| pubmed-article:19819617 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:19819617 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:19819617 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:19819617 | lifeskim:mentions | umls-concept:C0442124 | lld:lifeskim |
| pubmed-article:19819617 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19819617 | pubmed:dateCreated | 2010-2-24 | lld:pubmed |
| pubmed-article:19819617 | pubmed:abstractText | Bacillus Calmette-Guérin (BCG) instillation is regarded as the most effective bladder-sparing treatment for patients with high-grade T1 tumours and carcinoma in situ (CIS). The major problem with this therapy is the side-effects, making maintenance therapy difficult, even impossible, in a proportion of patients. Thus, alternative schedules and drugs have been proposed. | lld:pubmed |
| pubmed-article:19819617 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19819617 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19819617 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19819617 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19819617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19819617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19819617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19819617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19819617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19819617 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19819617 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19819617 | pubmed:issn | 1873-7560 | lld:pubmed |
| pubmed-article:19819617 | pubmed:author | pubmed-author:HellströmPekk... | lld:pubmed |
| pubmed-article:19819617 | pubmed:author | pubmed-author:MalmströmPer-... | lld:pubmed |
| pubmed-article:19819617 | pubmed:author | pubmed-author:JohanssonRobe... | lld:pubmed |
| pubmed-article:19819617 | pubmed:author | pubmed-author:MestadOddvarO | lld:pubmed |
| pubmed-article:19819617 | pubmed:author | pubmed-author:HellstenSverk... | lld:pubmed |
| pubmed-article:19819617 | pubmed:author | pubmed-author:DuchekMilosM | lld:pubmed |
| pubmed-article:19819617 | pubmed:author | pubmed-author:JahnsonStaffa... | lld:pubmed |
| pubmed-article:19819617 | pubmed:author | pubmed-author:Members of... | lld:pubmed |
| pubmed-article:19819617 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19819617 | pubmed:volume | 57 | lld:pubmed |
| pubmed-article:19819617 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19819617 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19819617 | pubmed:pagination | 25-31 | lld:pubmed |
| pubmed-article:19819617 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:meshHeading | pubmed-meshheading:19819617... | lld:pubmed |
| pubmed-article:19819617 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19819617 | pubmed:articleTitle | Bacillus Calmette-Guérin is superior to a combination of epirubicin and interferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer. A prospective, randomized, Nordic study. | lld:pubmed |
| pubmed-article:19819617 | pubmed:affiliation | Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University Hospital, Umeå, Sweden. | lld:pubmed |
| pubmed-article:19819617 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19819617 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19819617 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19819617 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19819617 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19819617 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19819617 | lld:pubmed |
